Novel biomarkers and therapeutic targets for prostate cancer

Frontiers in Bioscience - Scholar

Volumn 2 S, Issue 2, 2010, Pages 677-684

  Williams, Ryan M ^a   Naz, Rajesh K ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biomarkers; Carcinogenesis; Prostate cancer; Prostate genes; Prostates specific antigen (PSA)

Indexed keywords

ANO7 PROTEIN, HUMAN; C15ORF21 PROTEIN, HUMAN; CITRIC ACID; HIGH MOBILITY GROUP N2 PROTEIN; MEMBRANE PROTEIN; PROSTATE SPECIFIC ANTIGEN; SARCOSINE; TRANSCRIPTION FACTOR; TUMOR MARKER;

ENDOPLASMIC RETICULUM; GOLGI COMPLEX; HUMAN; MALE; METABOLISM; PROSTATE TUMOR; REVIEW;

CITRIC ACID; ENDOPLASMIC RETICULUM; GOLGI APPARATUS; HMGN2 PROTEIN; HUMANS; MALE; MEMBRANE PROTEINS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SARCOSINE; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 77957321508     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu and M. J. Thun: Cancer Statistics, 2009. CA Cancer J Clin (2009)
2. M. C. Wang, L. D. Papsidero, M. Kuriyama, L. A. Valenzuela, G. P. Murphy and T. M. Chu: Prostate antigen: a new potential marker for prostatic cancer. Prostate, 2 (1), 89-96 (1981) (Pubitemid 11030897)
3. J. E. Damber and G. Aus: Prostate cancer. Lancet, 371 (9625), 1710-21 (2008) (Pubitemid 351671887)
4. M. D. Galsky, M. Eisenberger, S. Moore-Cooper, W. K. Kelly, S. F. Slovin, A. DeLaCruz, Y. Lee, I. J. Webb and H. I. Scher: Phase I trial of the prostate-specific membrane antigen-directed immunoconjugate MLN2704 in patients with progressive metastatic castration-resistant prostate cancer. J Clin Oncol, 26 (13), 2147-54 (2008)
5. S. Ross, S. D. Spencer, I. Holcomb, C. Tan, J. Hongo, B. Devaux, L. Rangell, G. A. Keller, P. Schow, R. M. Steeves, R. J. Lutz, G. Frantz, K. Hillan, F. Peale, P. Tobin, D. Eberhard, M. A. Rubin, L. A. Lasky and H. Koeppen: Prostate stem cell antigen as therapy target: tissue expression and in vivo efficacy of an immunoconjugate. Cancer Res, 62 (9), 2546-53 (2002) (Pubitemid 34462733)
6. R. K. Naz and E. A. Herness: Prostate-specific genes: present status and future direction. Front Biosci, 6, D1083-8 (2001)
7. L. L. Xu, B. G. Stackhouse, K. Florence, W. Zhang, N. Shanmugam, I. A. Sesterhenn, Z. Zou, V. Srikantan, M. Augustus, V. Roschke, K. Carter, D. G. McLeod, J. W. Moul, D. Soppett and S. Srivastava: PSGR, a novel prostate-specific gene with homology to a G protein-coupled receptor, is overexpressed in prostate cancer. Cancer Res, 60 (23), 6568-72 (2000)
8. J. Weng, J. Wang, Y. Cai, L. J. Stafford, D. Mitchell, M. Ittmann and M. Liu: Increased expression of prostate-specific G-protein-coupled receptor in human prostate intraepithelial neoplasia and prostate cancers. Int J Cancer, 113 (5), 811-8 (2005) (Pubitemid 40101264)
9. B. Weigle, S. Fuessel, R. Ebner, A. Temme, M. Schmitz, S. Schwind, A. Kiessling, M. A. Rieger, A. Meye, M. Bachmann, M. P. Wirth and E. P. Rieber: D-GPCR: a novel putative G protein-coupled receptor overexpressed in prostate cancer and prostate. Biochem Biophys Res Commun, 322 (1), 239-49 (2004) (Pubitemid 39093861)
10. J. Weng, J. Wang, X. Hu, F. Wang, M. Ittmann and M. Liu: PSGR2, a novel G-protein coupled receptor, is overexpressed in human prostate cancer. Int J Cancer, 118 (6), 1471-80 (2006)
11. R. S. Hubert, I. Vivanco, E. Chen, S. Rastegar, K. Leong, S. C. Mitchell, R. Madraswala, Y. Zhou, J. Kuo, A. B. Raitano, A. Jakobovits, D. C. Saffran and D. E. Afar: STEAP: a prostate-specific cell-surface antigen highly expressed in human prostate tumors. Proc Natl Acad Sci U S A, 96 (25), 14523-8 (1999) (Pubitemid 30000683)
12. R. K. Naz, R. Santhanam and N. Tyagi: Novel human prostate-specific cDNA: molecular cloning, expression, and immunobiology of the recombinant protein. Biochem Biophys Res Commun, 297 (5), 1075-84 (2002) (Pubitemid 35216357)
13. E. A. Herness and R. K. Naz: A novel human prostate-specific gene-1 (HPG-1): molecular cloning, sequencing, and its potential involvement in prostate carcinogenesis. Cancer Res, 63 (2), 329-36 (2003) (Pubitemid 36152489)
14. T. K. Bera, S. Das, H. Maeda, R. Beers, C. D. Wolfgang, V. Kumar, Y. Hahn, B. Lee and I. Pastan: NGEP, a gene encoding a membrane protein detected only in prostate cancer and normal prostate. Proc Natl Acad Sci U S A, 101 (9), 3059-64 (2004) (Pubitemid 38327734)
15. A. Kiessling, B. Weigle, S. Fuessel, R. Ebner, A. Meye, M. A. Rieger, M. Schmitz, A. Temme, M. Bachmann, M. P. Wirth and E. P. Rieber: D-TMPP: a novel androgen-regulated gene preferentially expressed in prostate and prostate cancer that is the first characterized member of an eukaryotic gene family. Prostate, 64 (4), 387-400 (2005) (Pubitemid 41193252)
16. S. Das, Y. Hahn, S. Nagata, M. C. Willingham, T. K. Bera, B. Lee and I. Pastan: NGEP, a prostate-specific plasma membrane protein that promotes the association of LNCaP cells. Cancer Res, 67 (4), 1594-601 (2007) (Pubitemid 46383384)
17. V. Cereda, D. J. Poole, C. Palena, S. Das, T. K. Bera, C. Remondo, J. L. Gulley, P. M. Arlen, J. Yokokawa, I. Pastan, J. Schlom and K. Y. Tsang: New gene expressed in prostate: a potential target for T cell-mediated prostate cancer immunotherapy. Cancer Immunol Immunother (2009)
18. L. Tsavaler, M. H. Shapero, S. Morkowski and R. Laus: Trp-p8, a novel prostate-specific gene, is up-regulated in prostate cancer and other malignancies and shares high homology with transient receptor potential calcium channel proteins. Cancer Res, 61 (9), 3760-9 (2001) (Pubitemid 32694990)
19. L. L. Xu, N. Shanmugam, T. Segawa, I. A. Sesterhenn, D. G. McLeod, J. W. Moul and S. Srivastava: A novel androgen-regulated gene, PMEPA1, located on chromosome 20q13 exhibits high level expression in prostate. Genomics, 66 (3), 257-63 (2000) (Pubitemid 30481772)
20. J. Xu, M. Kalos, J. A. Stolk, E. J. Zasloff, X. Zhang, R. L. Houghton, A. M. Filho, M. Nolasco, R. Badaro and S. G. Reed: Identification and characterization of prostein, a novel prostate-specific protein. Cancer Res, 61 (4), 1563-8 (2001) (Pubitemid 34292588)
21. M. Kalos, J. Askaa, B. L. Hylander, E. A. Repasky, F. Cai, T. Vedvick, S. G. Reed, G. L. Wright, Jr. and G. R. Fanger: Prostein expression is highly restricted to normal and malignant prostate tissues. Prostate, 60 (3), 246-56 (2004) (Pubitemid 38971836)
22. K. S. Korkmaz, C. Elbi, C. G. Korkmaz, M. Loda, G. L. Hager and F. Saatcioglu: Molecular cloning and characterization of STAMP1, a highly prostate-specific six transmembrane protein that is overexpressed in prostate cancer. J Biol Chem, 277 (39), 36689-96 (2002)
23. K. P. Porkka, M. A. Helenius and T. Visakorpi: Cloning and characterization of a novel six-transmembrane protein STEAP2, expressed in normal and malignant prostate. Lab Invest, 82 (11), 1573-82 (2002) (Pubitemid 35332916)
24. R. S. Ohgami, D. R. Campagna, A. McDonald and M. D. Fleming: The Steap proteins are metalloreductases. Blood, 108 (4), 1388-94 (2006) (Pubitemid 44232042)
25. S. Varambally, B. Laxman, R. Mehra, Q. Cao, S. M. Dhanasekaran, S. A. Tomlins, J. Granger, A. Vellaichamy, A. Sreekumar, J. Yu, W. Gu, R. Shen, D. Ghosh, L. M. Wright, R. D. Kladney, R. Kuefer, M. A. Rubin, C. J. Fimmel and A. M. Chinnaiyan: Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer. Neoplasia, 10 (11), 1285-94 (2008)
26. Y. Lu, Y. Yi, P. Liu, W. Wen, M. James, D. Wang and M. You: Common human cancer genes discovered by integrated gene-expression analysis. PLoS One, 2 (11), e1149 (2007)
27. M. O. Riener, F. Stenner, H. Liewen, C. Soll, S. Breitenstein, B. C. Pestalozzi, P. Samaras, N. Probst-Hensch, C. Hellerbrand, B. Mullhaupt, P. A. Clavien, M. Bahra, P. Neuhaus, P. Wild, F. Fritzsche, H. Moch, W. Jochum and G. Kristiansen: Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas. Hepatology, 49 (5), 1602-9 (2009)
28. R. Wang, J. Xu, O. Saramaki, T. Visakorpi, W. M. Sutherland, J. Zhou, B. Sen, S. D. Lim, N. Mabjeesh, M. Amin, J. T. Dong, J. A. Petros, P. S. Nelson, F. F. Marshall, H. E. Zhau and L. W. Chung: PrLZ, a novel prostate-specific and androgen-responsive gene of the TPD52 family, amplified in chromosome 8q21.1 and overexpressed in human prostate cancer. Cancer Res, 64 (5), 1589-94 (2004) (Pubitemid 38428676)
29. R. Wang, J. Xu, N. Mabjeesh, G. Zhu, J. Zhou, M. Amin, D. He, F. F. Marshall, H. E. Zhau and L. W. Chung: PrLZ is expressed in normal prostate development and in human prostate cancer progression. Clin Cancer Res, 13 (20), 6040-8 (2007) (Pubitemid 350075060)
30. H. Qi, C. Fillion, Y. Labrie, J. Grenier, A. Fournier, L. Berger, M. El-Alfy and C. Labrie: AIbZIP, a novel bZIP gene located on chromosome 1q21.3 that is highly expressed in prostate tumors and of which the expression is up-regulated by androgens in LNCaP human prostate cancer cells. Cancer Res, 62 (3), 721-33 (2002) (Pubitemid 34126947)
31. A. Ohkia, Y. Hu, M. Wang, F. U. Garcia and M. E. Stearns: Evidence for prostate cancer-associated diagnostic marker-1: immunohistochemistry and in situ hybridization studies. Clin Cancer Res, 10 (7), 2452-8 (2004) (Pubitemid 38445706)
32. Z. Z. Su, J. Lin, R. Shen, P. E. Fisher, N. I. Goldstein and P. B. Fisher: Surface-epitope masking and expression cloning identifies the human prostate carcinoma tumor antigen gene PCTA-1 a member of the galectin gene family. Proc Natl Acad Sci U S A, 93 (14), 7252-7 (1996) (Pubitemid 26243535)
33. R. V. Gopalkrishnan, T. Roberts, S. Tuli, D. Kang, K. A. Christiansen and P. B. Fisher: Molecular characterization of prostate carcinoma tumor antigen-1, PCTA-1, a human galectin-8 related gene. Oncogene, 19 (38), 4405-16 (2000)
34. N. Konishi, M. Nakamura, E. Ishida, K. Shimada, E. Mitsui, R. Yoshikawa, H. Yamamoto and K. Tsujikawa: High expression of a new marker PCA-1 in human prostate carcinoma. Clin Cancer Res, 11 (14), 5090-7 (2005) (Pubitemid 41003692)
35. B. Lin, J. T. White, C. Ferguson, R. Bumgarner, C. Friedman, B. Trask, W. Ellis, P. Lange, L. Hood and P. S. Nelson: PART-1: a novel human prostate-specific, androgen-regulated gene that maps to chromosome 5q12. Cancer Res, 60 (4), 858-63 (2000) (Pubitemid 30129515)
36. M. Sidiropoulos, A. Chang, K. Jung and E. P. Diamandis: Expression and regulation of prostate androgen regulated transcript-1 (PART-1) and identification of differential expression in prostatic cancer. Br J Cancer, 85 (3), 393-7 (2001) (Pubitemid 32747708)
37. B. Weigle, A. Kiessling, R. Ebner, S. Fuessel, A. Temme, A. Meye, M. Schmitz, M. A. Rieger, D. Ockert, M. P. Wirth and E. P. Rieber: D-PCa-2: a novel transcript highly overexpressed in human prostate and prostate cancer. Int J Cancer, 109 (6), 882-92 (2004) (Pubitemid 38500745)
38. A. Kaushal, S. A. Myers, Y. Dong, J. Lai, O. L. Tan, L. T. Bui, M. L. Hunt, M. R. Digby, H. Samaratunga, R. A. Gardiner, J. A. Clements and J. D. Hooper: A novel transcript from the KLKP1 gene is androgen regulated, down-regulated during prostate cancer progression and encodes the first non-serine protease identified from the human kallikrein gene locus. Prostate, 68 (4), 381-99 (2008) (Pubitemid 351342644)
39. A. Sreekumar, L. M. Poisson, T. M. Rajendiran, A. P. Khan, Q. Cao, J. Yu, B. Laxman, R. Mehra, R. J. Lonigro, Y. Li, M. K. Nyati, A. Ahsan, S. Kalyana-Sundaram, B. Han, X. Cao, J. Byun, G. S. Omenn, D. Ghosh, S. Pennathur, D. C. Alexander, A. Berger, J. R. Shuster, J. T. Wei, S. Varambally, C. Beecher and A. M. Chinnaiyan: Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature, 457 (7231), 910-4 (2009)
40. E. E. Kline, E. G. Treat, T. A. Averna, M. S. Davis, A. Y. Smith and L. O. Sillerud: Citrate concentrations in human seminal fluid and expressed prostatic fluid determined via 1H nuclear magnetic resonance spectroscopy outperform prostate specific antigen in prostate cancer detection. J Urol, 176 (5), 2274-9 (2006) (Pubitemid 44633142)
41. N. J. Serkova, E. J. Gamito, R. H. Jones, C. O'Donnell, J. L. Brown, S. Green, H. Sullivan, T. Hedlund and E. D. Crawford: The metabolites citrate, myo-inositol, and spermine are potential age-independent markers of prostate cancer in human expressed prostatic secretions. Prostate, 68 (6), 620-8 (2008) (Pubitemid 351614640)
42. I. L. Deras, S. M. Aubin, A. Blase, J. R. Day, S. Koo, A. W. Partin, W. J. Ellis, L. S. Marks, Y. Fradet, H. Rittenhouse and J. Groskopf: PCA3: a molecular urine assay for predicting prostate biopsy outcome. J Urol, 179 (4), 1587-92 (2008)
43. P. M. Arlen, M. Mohebtash, R. A. Madan and J. L. Gulley: Promising novel immunotherapies and combinations for prostate cancer. Future Oncol, 5 (2), 187-96 (2009)